John A Mankovich

This inventor holds 17 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Human Antibodies. Top assignees: Abbott Biotechnology Ltd., Basf Aktiengesellschaft, Abbott Laboratories Corporation. Active years: 1998-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John A Mankovich. Retrieved from https://idiyas.com/inventor/john-a-mankovich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 7)

% Patents Active = 35.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 8.1

ph-index = 14

Forward Citations = 1,897(Granted Patents)

Company Filing History:

8 out of 17

Abbott Biotechnology Ltd.

patents

7 out of 10,816

Basf Aktiengesellschaft

patents

1 out of 4,189

Abbott Laboratories Corporation

patents

4. 1 out of 93

Abbvie Biotechnology Ltd

patents

Years Active: 1998-2014

Loading Chart...

Areas of Expertise:

Human Antibodies

TNFα

Rheumatoid Arthritis

IL-18

Interleukin-1

Protein Expression

Antibody Therapeutics

Disorder Treatment

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8753633 - Human antibodies that bind human TNFα (2014-06-17),

2. 8414894 - Human antibodies that bind human TNFα and methods of using same (2013-04-09),

3. 8372401 - Human antibodies that bind human TNFα (2013-02-12),

4. 8372400 - Methods of treating disorders using human antibodies that bind human TNFα (2013-02-12),

5. 8206714 - Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa (2012-06-26),

6. 8197813 - Human antibodies that bind human TNFα (2012-06-12),

7. 7767207 - Antibodies that bind IL-18 and methods of inhibiting IL-18 activity (2010-08-03),

8. 7588761 - Human antibodies that bind human TNFα (2009-09-15),

9. 7541031 - Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα (2009-06-02),

10. 7223394 - Human antibodies that bind human TNFα (2007-05-29),

11. 6524807 - Modified interleukin-1&bgr; converting enzyme with increased stability (2003-02-25),

12. 6509015 - Human antibodies that bind human TNFa (2003-01-21),

13. 6258562 - Human antibodies that bind human TNF&agr; (2001-07-10),

14. 6242240 - Modified interleukin-1&bgr; converting enzyme with increased stability (2001-06-05),

15. 6090382 - Human antibodies that bind human TNF.alpha. (2000-07-18),

Title: The Innovative Journey of John A. Mankovich

Introduction:

John A. Mankovich, a talented inventor hailing from Andover, MA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

John A. Mankovich holds several patents in various technological domains, showcasing his versatility and creativity in inventing new solutions to complex problems.

Career Highlights:

Throughout his illustrious career, John A. Mankovich has been at the forefront of technological advancements, consistently pushing the boundaries of innovation. His dedication to creating cutting-edge solutions has earned him recognition as a pioneer in the industry.

Collaborations:

John A. Mankovich has collaborated with leading tech companies, research institutions, and universities to further his inventions and bring them to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, John A. Mankovich's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor. His contributions to the world of technology continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.